Novartis’s MS Franchise Setback For Ofatumumab In US

FDA Extends Review Time To September 2020

 
• By John Davis
  
Nerve_Cells
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category